COVID-19

Oasis Employee Appreciation Month for August 2023

LAS VEGAS, NV / ACCESSWIRE / August 2, 2023 / Oasis Cannabis Dispensary has been recognized as the "locals'" dispensary…

1 year ago

Aridis Pharmaceuticals Announces $2 Million Offering

Los Gatos, Calif., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (OTC: ARDS), a biopharmaceutical company focused on the…

1 year ago

DLH to Expand Digital Transformation Services at the National Heart, Lung, and Blood Institute

ATLANTA, Aug. 02, 2023 (GLOBE NEWSWIRE) -- DLH Holdings Corp. (NASDAQ: DLHC) (“DLH” or the “Company”), a leading provider of…

1 year ago

Advanced Health Intelligence to re-enter China with Exclusive License Deal with Changlin Network Technology Ltd

HighlightsAHI executes a binding exclusive, perpetual license with Shanghai-based Changlin Network Technology Ltd.Changlin is backed by founders with 50 years…

1 year ago

Aptevo Therapeutics Inc. Announces Pricing of $5 Million Public Offering

SEATTLE, WA / ACCESSWIRE / August 1, 2023 / Aptevo Therapeutics Inc. (NASDAQ:APVO) ("Aptevo" or the "Company"), a clinical stage…

1 year ago

Verily Appoints Andrew Trister, MD, PhD as Chief Scientific Officer

Health AI and digital health leader brings decades of experience advancing population health initiatives at Apple and The Bill &…

1 year ago

AHI Commentary for the Quarter Ended 30 June 2023

HighlightsExpanded Partner Opportunities in the UAE. AHI commenced Stellenbosch University joint study.AHI entered US FDA submissions.AHI clears NASDAQ Compliance Requirements.AHI…

1 year ago

CureVac Announces Dosing of First Participant in Phase 2 Study of Modified COVID-19 mRNA Vaccine Candidates Developed in Collaboration with GSK

Phase 2 study initiated at clinical sites in Australia with monovalent and bivalent mRNA COVID-19 vaccine candidatesVaccine candidates developed in…

1 year ago

Precipio Unaudited Q2-2023 Revenues Show combined increase of 25% over Q1-2023

Revenue growth and customer pipeline advance the Company towards breakevenNEW HAVEN, Conn., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Specialty cancer…

1 year ago

Hologic Announces Financial Results for Third Quarter of Fiscal 2023

– Revenue of $984.4 Million, GAAP Diluted EPS of ($0.16), and Non-GAAP Diluted EPS of $0.93 – – Total Company…

1 year ago